AR003122A1 - A PROCESS FOR ISOLATION AND PURIFICATION OF PLASMIDS IN LARGE SCALE FERMENTATORS AND ISOLATED AND PURIFIED DNA OBTAINED THROUGH SUCH A PROCESS. - Google Patents
A PROCESS FOR ISOLATION AND PURIFICATION OF PLASMIDS IN LARGE SCALE FERMENTATORS AND ISOLATED AND PURIFIED DNA OBTAINED THROUGH SUCH A PROCESS.Info
- Publication number
- AR003122A1 AR003122A1 ARP960102507A AR10250796A AR003122A1 AR 003122 A1 AR003122 A1 AR 003122A1 AR P960102507 A ARP960102507 A AR P960102507A AR 10250796 A AR10250796 A AR 10250796A AR 003122 A1 AR003122 A1 AR 003122A1
- Authority
- AR
- Argentina
- Prior art keywords
- purification
- isolation
- fermentators
- plasmids
- isolated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/06—Lysis of microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1017—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Se describe un proceso para la aislación y purificación a gran escala de ADN de plasmidios a partir de fermentaciones microbianas a gran escala. Todaslas tres formas de ADN de plasmidio: super-enrollado (forma 1), círculo abierto o relajado (forma2) y linearizado (forma 3) son aislables individualmenteusando el proceso revelado. Se provee, mediante el proceso revelado, ADN altamente purificado, adecuado para incluirlo en composiciones farmacéuticas.A process for the large-scale isolation and purification of plasmid DNA from large-scale microbial fermentations is described. All three forms of plasmid DNA: super-coiled (form 1), open or relaxed circle (form 2), and linearized (form 3) are individually isolatable using the disclosed process. Highly purified DNA suitable for inclusion in pharmaceutical compositions is provided by the disclosed process.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44611895A | 1995-05-19 | 1995-05-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR003122A1 true AR003122A1 (en) | 1998-07-08 |
Family
ID=23771380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960102507A AR003122A1 (en) | 1995-05-19 | 1996-05-09 | A PROCESS FOR ISOLATION AND PURIFICATION OF PLASMIDS IN LARGE SCALE FERMENTATORS AND ISOLATED AND PURIFIED DNA OBTAINED THROUGH SUCH A PROCESS. |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0827536A1 (en) |
JP (1) | JPH11505707A (en) |
KR (1) | KR19990014924A (en) |
CN (1) | CN1190435A (en) |
AR (1) | AR003122A1 (en) |
AU (1) | AU709003B2 (en) |
CA (1) | CA2220867A1 (en) |
CZ (1) | CZ366197A3 (en) |
EA (1) | EA000785B1 (en) |
HR (1) | HRP960222A2 (en) |
HU (1) | HUP9802557A3 (en) |
MX (1) | MX9708967A (en) |
NO (1) | NO975280L (en) |
NZ (1) | NZ309231A (en) |
PL (1) | PL323475A1 (en) |
SK (1) | SK155797A3 (en) |
WO (1) | WO1996036706A1 (en) |
YU (1) | YU29796A (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2192342A1 (en) * | 1994-07-15 | 1996-02-01 | Ann L. Lee | A method for large scale plasmid purification |
US6197553B1 (en) | 1994-07-15 | 2001-03-06 | Merck & Co., Inc. | Method for large scale plasmid purification |
GB9425138D0 (en) | 1994-12-12 | 1995-02-08 | Dynal As | Isolation of nucleic acid |
US5981735A (en) * | 1996-02-12 | 1999-11-09 | Cobra Therapeutics Limited | Method of plasmid DNA production and purification |
FR2753204B1 (en) * | 1996-09-11 | 1998-12-04 | Transgene Sa | PROCESS FOR THE PREPARATION OF PLASMID DNA |
SE9703532D0 (en) * | 1997-09-30 | 1997-09-30 | Pharmacia Biotech Ab | A process for the purification of plasmid DNA |
US6914137B2 (en) | 1997-12-06 | 2005-07-05 | Dna Research Innovations Limited | Isolation of nucleic acids |
AU4314099A (en) * | 1998-06-01 | 1999-12-20 | Immune Response Corporation, The | Novel method of large scale plasmid purification |
US6270970B1 (en) | 1999-05-14 | 2001-08-07 | Promega Corporation | Mixed-bed solid phase and its use in the isolation of nucleic acids |
US6310199B1 (en) | 1999-05-14 | 2001-10-30 | Promega Corporation | pH dependent ion exchange matrix and method of use in the isolation of nucleic acids |
US20020012990A1 (en) | 1999-12-22 | 2002-01-31 | Lander Russel Jackson | Process for the scaleable purification of plasmid DNA |
ATE309344T1 (en) | 2001-01-19 | 2005-11-15 | Mueller Drm Ag | METHOD FOR PREPARING BIOMASS FOR PRODUCING CELL LYSATE CONTAINING PLASMID DNA |
GB0107634D0 (en) | 2001-03-27 | 2001-05-16 | Fermentas Ab | Nucleic acid purification |
US6406892B1 (en) | 2001-05-23 | 2002-06-18 | Bio-Rad Laboratories, Inc. | Acetate-free purification of plasmid DNA on hydroxyapatite |
US8501402B2 (en) | 2003-03-24 | 2013-08-06 | Boehringer Ingelheim Rcv Gmbh & Co Kg | Methods and devices for producing biomolecules |
CA2595594C (en) | 2005-01-31 | 2012-05-01 | Merck & Co., Inc. | Upstream and a downstream purification process for large scale production of plasmid dna |
JP2006238822A (en) * | 2005-03-04 | 2006-09-14 | Fuji Photo Film Co Ltd | Method for separating and purifying nucleic acid |
DE102005059315A1 (en) * | 2005-12-09 | 2007-06-14 | Qiagen Gmbh | Process for the enrichment of short-chain nucleic acids |
CN100439497C (en) * | 2006-05-26 | 2008-12-03 | 吉林大学 | Purification method adapted to mass production of plasmid DNA |
EP2081442B1 (en) * | 2006-10-10 | 2016-08-10 | TrovaGene, Inc. | Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media |
CN101702938A (en) * | 2007-05-23 | 2010-05-05 | Vgx药品公司 | Composition comprising high concentration of biologically active molecules and processes for preparing the same |
CN101070543B (en) * | 2007-06-01 | 2010-12-29 | 广东药学院 | Super spirial plasmid separation purifying process |
GB0913160D0 (en) * | 2009-07-29 | 2009-09-02 | Avecia Biolog Ltd | Extraction process |
EP2556143B1 (en) * | 2010-04-08 | 2016-12-07 | Qiagen GmbH | Method for isolating and purifying nucleic acids |
JP2013528786A (en) | 2010-04-08 | 2013-07-11 | キアゲン ゲーエムベーハー | Chromatographic device and method for isolating and purifying nucleic acids |
JP5624487B2 (en) * | 2011-01-31 | 2014-11-12 | 横河電機株式会社 | Nucleic acid extraction method |
ES2656947T3 (en) | 2011-04-27 | 2018-03-01 | Merck Patent Gmbh | Method to lyse cells |
CN104099321A (en) * | 2014-07-10 | 2014-10-15 | 广州市军科泰特医药科技有限公司 | Preparation method of lung cancer resistant plasmid T-VISA (VP16-Gal4-WPRE integrated systemic amplifier)-Bik (bcl-2interacting killer) DD |
CN106884011B (en) * | 2015-12-16 | 2020-11-17 | 固安鼎泰海规生物科技有限公司 | Combined liquid chromatography separation method for large-scale plasmid purification |
CN111721871A (en) * | 2020-06-24 | 2020-09-29 | 南京济群生物科技有限公司 | High-resolution detection method for plasmid supercoiled DNA content |
CN112798697B (en) * | 2020-11-16 | 2022-11-22 | 武汉波睿达生物科技有限公司 | Detection method for supercoiled structure purity of lentivirus packaging system helper plasmid |
CN114456940B (en) * | 2022-01-23 | 2024-05-03 | 和元生物技术(上海)股份有限公司 | Method for improving plasmid stability in escherichia coli cracking process |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0800830A3 (en) * | 1989-11-03 | 1999-03-17 | Vanderbilt University | Method of in vivo delivery of functioning foreign genes |
EP0646178A1 (en) * | 1992-06-04 | 1995-04-05 | The Regents Of The University Of California | expression cassette with regularoty regions functional in the mammmlian host |
US5834441A (en) * | 1993-09-13 | 1998-11-10 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Adeno-associated viral (AAV) liposomes and methods related thereto |
CA2192342A1 (en) * | 1994-07-15 | 1996-02-01 | Ann L. Lee | A method for large scale plasmid purification |
-
1996
- 1996-05-09 AR ARP960102507A patent/AR003122A1/en unknown
- 1996-05-15 WO PCT/US1996/007083 patent/WO1996036706A1/en not_active Application Discontinuation
- 1996-05-15 KR KR1019970708270A patent/KR19990014924A/en not_active Application Discontinuation
- 1996-05-15 MX MX9708967A patent/MX9708967A/en not_active IP Right Cessation
- 1996-05-15 HR HR08/446,118A patent/HRP960222A2/en not_active Application Discontinuation
- 1996-05-15 SK SK1557-97A patent/SK155797A3/en unknown
- 1996-05-15 CN CN96195329A patent/CN1190435A/en active Pending
- 1996-05-15 JP JP8535061A patent/JPH11505707A/en not_active Withdrawn
- 1996-05-15 CZ CZ973661A patent/CZ366197A3/en unknown
- 1996-05-15 AU AU59219/96A patent/AU709003B2/en not_active Ceased
- 1996-05-15 NZ NZ309231A patent/NZ309231A/en unknown
- 1996-05-15 EA EA199700399A patent/EA000785B1/en not_active IP Right Cessation
- 1996-05-15 HU HU9802557A patent/HUP9802557A3/en unknown
- 1996-05-15 PL PL96323475A patent/PL323475A1/en unknown
- 1996-05-15 CA CA002220867A patent/CA2220867A1/en not_active Abandoned
- 1996-05-15 EP EP96916486A patent/EP0827536A1/en not_active Withdrawn
- 1996-05-17 YU YU29796A patent/YU29796A/en unknown
-
1997
- 1997-11-18 NO NO975280A patent/NO975280L/en unknown
Also Published As
Publication number | Publication date |
---|---|
JPH11505707A (en) | 1999-05-25 |
WO1996036706A1 (en) | 1996-11-21 |
HUP9802557A3 (en) | 2000-04-28 |
NO975280L (en) | 1998-01-16 |
CA2220867A1 (en) | 1996-11-21 |
YU29796A (en) | 1999-06-15 |
PL323475A1 (en) | 1998-03-30 |
KR19990014924A (en) | 1999-02-25 |
CN1190435A (en) | 1998-08-12 |
HRP960222A2 (en) | 1997-12-31 |
EA199700399A1 (en) | 1998-06-25 |
HUP9802557A2 (en) | 1999-02-01 |
MX9708967A (en) | 1998-03-31 |
NZ309231A (en) | 1999-10-28 |
NO975280D0 (en) | 1997-11-18 |
SK155797A3 (en) | 1998-07-08 |
EA000785B1 (en) | 2000-04-24 |
CZ366197A3 (en) | 1998-04-15 |
EP0827536A1 (en) | 1998-03-11 |
AU709003B2 (en) | 1999-08-19 |
AU5921996A (en) | 1996-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR003122A1 (en) | A PROCESS FOR ISOLATION AND PURIFICATION OF PLASMIDS IN LARGE SCALE FERMENTATORS AND ISOLATED AND PURIFIED DNA OBTAINED THROUGH SUCH A PROCESS. | |
DK0923592T3 (en) | Methods for purifying nucleic acids | |
ATE277175T1 (en) | A PROCESS FOR LARGE SCALE PLASMIDS CLEANING | |
ATE99358T1 (en) | ALPHA-1 ANTI-TRYPSIN MUTANTS AND DNA ENCODING THEREFORE AND PRODUCTION SAME, AND THERAPEUTIC COMPOSITIONS USING SUCH MUTANTS AND THEIR PRODUCTION. | |
NO943038D0 (en) | Method of Preparation of Virus Resistant Plants via Introduction of Untranslatable Plus RNA | |
AU2002354853A1 (en) | Process for the preparation of l-amino acids using strains of the enterobacteriaceae family | |
PT937098E (en) | IN VITRO RECOMBINATION CLONING USING MODIFIED RECOMBINATION PLACES | |
ATE131161T1 (en) | SUBSTANCE PF 1022, METHOD FOR THE PRODUCTION THEREOF AND ANTHELMINTIC COMPOSITION CONTAINING THIS SUBSTANCE. | |
DK1042340T3 (en) | 6-O-B-alkylerythromycinoxim | |
DK0653436T3 (en) | 5-Methyluridine Large Scale Preparation of 2 ', 3'-Didehydro-3'-Deoxythymidine (d4T) | |
AU6766487A (en) | Purification of pertussis antigens | |
FR2641285B1 (en) | GLUCOSE-6-PHOSPHATE DEHYDROGENASE GENE, PLASMID AND MICROORGANISM CONTAINING THE SAME AND PROCESS FOR THE PREPARATION OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE | |
FR2768736B1 (en) | NOVEL TRICYCLIC COMPOUNDS, THEIR PREPARATION PROCESS AND INTERMEDIATES THEREOF, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
CA2226457A1 (en) | Oligonucleotides specific for human papilloma virus | |
FR2747680B1 (en) | NOVEL STEROIDS, THEIR APPLICATION AS MEDICAMENTS, THEIR PREPARATION PROCESS, THE INTERMEDIATES THEREOF AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
DE69331216D1 (en) | PLANT RESISTANT TO AT LEAST TWO VIRUSES AND THEIR PREPARATION | |
NO20004613L (en) | Method of Preparation of a Tetrapeptide | |
WO1994020604A3 (en) | Agricultural-chemical-producing endosymbiotic microorganisms and method of preparing and using same | |
HUP0105166A2 (en) | Substances wk-5344a and wk-5344b and process for producing the same | |
ES8604022A1 (en) | Process for the isolation and purification of alpha-interferons. | |
JPS5459392A (en) | Novel nuclease and its preparation | |
ATE346920T1 (en) | NEW IMMUNO-REGULATORY PROTEIN LST-1 | |
JPS5539730A (en) | Preparation of ubiquinone q10 | |
FR2681598B1 (en) | NOVEL DECAHYDROQUINOLEIN DERIVATIVES, THEIR PREPARATION PROCESS, THE PREPARATION INTERMEDIATES, THEIR APPLICATION AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM. | |
DE3882654D1 (en) | ENZYME INHIBITORS AND METHOD FOR THE PRODUCTION THEREOF. |